Skip to main content

Can you take Cangrelor with Plasminogen, human?

1 drug interaction and 1 additional warning found for the following 2 drugs:

Add/remove drugs

Drug interactions

Major drug interactions

Major:

cangrelor plasminogen, human

Applies to: cangrelor and plasminogen, human

Using plasminogen, human together with cangrelor may increase the risk of bleeding.

Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications.

You should seek immediate medical attention if you experience any unusual bleeding or bruising or have other signs and symptoms of bleeding such as:

  • dizziness
  • lightheadedness
  • red or black, tarry stools
  • coughing up or vomiting fresh or dried blood that looks like coffee grounds
  • severe headache
  • weakness

It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Food/lifestyle interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Disease interactions

1 potential interaction Applies to: 1 condition, including Bleeding Disorder.

Bleeding Disorder

Major:

cangrelor

Cangrelor has a major potential interaction with Bleeding Disorder.

Cangrelor is contraindicated in patients with significant active bleeding.

More resources

cangrelor

A total of 155 drugs are known to interact with cangrelor.

plasminogen, human

A total of 77 drugs are known to interact with plasminogen, human.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.